Auffinger B - Search Results

1

A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.

Ahmed AU, Thaci B, Tobias AL, Auffinger B, Zhang L, Cheng Y, Kim CK, Yunis C, Han Y, Alexiades NG, Fan X, Aboody KS, Lesniak MS. Ahmed AU, et al. Among authors: auffinger b. J Natl Cancer Inst. 2013 Jul 3;105(13):968-77. doi: 10.1093/jnci/djt141. J Natl Cancer Inst. 2013. PMID: 23821758 Free PMC article.

2

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.

Auffinger B, Tobias AL, Han Y, Lee G, Guo D, Dey M, Lesniak MS, Ahmed AU. Auffinger B, et al. Cell Death Differ. 2014 Jul;21(7):1119-31. doi: 10.1038/cdd.2014.31. Epub 2014 Mar 7. Cell Death Differ. 2014. PMID: 24608791 Free PMC article.

3

Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.

Auffinger B, Ahmed AU, Lesniak MS. Auffinger B, et al. Front Oncol. 2013 Feb 25;3:32. doi: 10.3389/fonc.2013.00032. eCollection 2013. Front Oncol. 2013. PMID: 23443138 Free PMC article.

4

Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?

Auffinger B, Morshed R, Tobias A, Cheng Y, Ahmed AU, Lesniak MS. Auffinger B, et al. Oncotarget. 2013 Mar;4(3):378-96. doi: 10.18632/oncotarget.937. Oncotarget. 2013. PMID: 23594406 Free PMC article. Review.

5

Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies.

Ahmed AU, Auffinger B, Lesniak MS. Ahmed AU, et al. Among authors: auffinger b. Expert Rev Neurother. 2013 May;13(5):545-55. doi: 10.1586/ern.13.42. Expert Rev Neurother. 2013. PMID: 23621311 Free PMC article. Review.

6

Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy.

Cheng Y, Morshed R, Cheng SH, Tobias A, Auffinger B, Wainwright DA, Zhang L, Yunis C, Han Y, Chen CT, Lo LW, Aboody KS, Ahmed AU, Lesniak MS. Cheng Y, et al. Among authors: auffinger b. Small. 2013 Dec 20;9(24):4123-9. doi: 10.1002/smll.201301111. Epub 2013 Jul 21. Small. 2013. PMID: 23873826 Free PMC article.

7

N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.

Kim CK, Ahmed AU, Auffinger B, Ulasov IV, Tobias AL, Moon KS, Lesniak MS. Kim CK, et al. Among authors: auffinger b. Mol Ther. 2013 Nov;21(11):2063-73. doi: 10.1038/mt.2013.179. Epub 2013 Jul 25. Mol Ther. 2013. PMID: 23883863 Free PMC article.

8

The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.

Tobias AL, Thaci B, Auffinger B, Rincón E, Balyasnikova IV, Kim CK, Han Y, Zhang L, Aboody KS, Ahmed AU, Lesniak MS. Tobias AL, et al. Among authors: auffinger b. Stem Cells Transl Med. 2013 Sep;2(9):655-66. doi: 10.5966/sctm.2013-0039. Epub 2013 Aug 7. Stem Cells Transl Med. 2013. PMID: 23926209 Free PMC article.

9

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.

Ulasov I, Thaci B, Sarvaiya P, Yi R, Guo D, Auffinger B, Pytel P, Zhang L, Kim CK, Borovjagin A, Dey M, Han Y, Baryshnikov AY, Lesniak MS. Ulasov I, et al. Among authors: auffinger b. Cancer Med. 2013 Aug;2(4):457-67. doi: 10.1002/cam4.104. Epub 2013 Jun 30. Cancer Med. 2013. PMID: 24156018 Free PMC article.

10

Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?

Dey M, Auffinger B, Lesniak MS, Ahmed AU. Dey M, et al. Among authors: auffinger b. Future Virol. 2013 Jul;8(7):675-693. doi: 10.2217/fvl.13.47. Future Virol. 2013. PMID: 24910708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page